About P3P Version number: 23.1 (98fb5f469)

P3P is a web-based program to help men prepare for making a decision, with their doctors, about how to manage a diagnosis of early stage prostate cancer. A recent national study* showed that using P3P reduced the amount of conflict experienced by men while making a decision.

This newest version of P3P (2021) has been developed in collaboration between professional stakeholders and the Clinical Informatics Research Group at the University of Washington in Seattle. The content of P3P was last updated in September, 2021 with the input of clinical professionals at:

  • Emory University
  • University of Kansas
  • University of Michigan
  • University of Southern California
  • University of Washington

University of Washington
Donna Berry, Justin McReynolds, Ivan Cvitkovic, William Lober

To use P3P in your clinic, or if you have questions about P3P, contact p3phelp@uw.edu

Berry DL, Hong F, Blonquist TM, Halpenny B, Filson CP, Master VA, Sanda MG, Chang P, Chien GW, Jones RA, Krupski TL, Wolpin S, Wilson L, Hayes JH, Trinh QD, Sokoloff M, Somayaji P: Decision Support with the Personal Patient Profile-Prostate: A Multi-Center Randomized Trial. Journal of Urology, 2017; PMID: 28754540

National Institutes of Health Funding: R21 CA100025; 2003-2005; R01NR009692; 2006-2009; 2012-2017

Funding Acknowledgements

P3P was developed based on research made possible by the following:

National Cancer Institute, National Institutes of Health

  • R29 CA77372; 1998-2003
  • R21 CA 100025; 2003-2005

National Institute of Nursing Research, National Institutes of Health

  • R01 NR009692; 2006-2009; 2012-2017

A. David Mazzone Research Awards Program, Dana-Farber/Harvard Cancer Center

  • 2011-2013

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.


Copyright © Dana-Farber Cancer Institute and University of Washington, 2002-2023. All rights reserved.

This software and documentation contain valuable trade secrets and proprietary information belonging to Dana-Farber Cancer Institute and University of Washington. None of the foregoing material may be copied, duplicated or disclosed without the express written permission of Dana-Farber Cancer Institute and University of Washington. Dana-Farber Cancer Institute and the University of Washington EXPRESSLY DISCLAIM ANY AND ALL WARRANTIES CONCERNING THIS SOFTWARE AND DOCUMENTATION, INCLUDING ANY WARRANTIES OF MERCHANTABILITY AND/OR FITNESS FOR ANY PARTICULAR PURPOSE, AND WARRANTIES OF PERFORMANCE, AND ANY WARRANTY THAT MIGHT OTHERWISE ARISE FROM COURSE OF DEALING OR USAGE OF TRADE. NO WARRANTY IS EITHER EXPRESS OR IMPLIED WITH RESPECT TO THE USE OF THE SOFTWARE OR DOCUMENTATION. Under no circumstances, shall Dana-Farber Cancer Institute or the University of Washington be liable for incidental, special, indirect, direct or consequential damages or loss of profits, interruption of business, or related expenses which may arise from the use of the software or documentation, including but not limited to those resulting from defects in software and/or documentation, or loss or inaccuracy of data of any kind.